DTaP-IPV-HepB vaccine

DTaP-IPV-HepB vaccine
Combination of
DTaP vaccineVaccine
Inactivated poliovirus vaccineVaccine
Hepatitis B vaccineVaccine
Names
Trade namesPediarix
Clinical data
WHO AWaReUnlinkedWikibase error: ⧼unlinkedwikibase-error-statements-entity-not-set⧽
Pregnancy
category
  • US: C (Risk not ruled out)
    Routes of
    use
    IM
    External links
    AHFS/Drugs.comPediarix
    MedlinePlusa607014
    Legal
    License data
    Legal status
    Identifiers
    CAS Number
    • 308079-75-6
    ATC code

    DTaP-IPV-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated polio vaccine or DTaP-IPV-Hep B.[1]

    It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and hepatitis B.[2][3][4]

    A branded formulation is marketed in the U.S. as Pediarix by GlaxoSmithKline.[5]

    References

    1. "Diphtheria, Tetanus Toxoids, Acellular Pertussis, Hepatitis B (Recombinant), and Poliovirus (Inactivated) Vaccine". Drugs.com. Retrieved 15 July 2018.
    2. Centers for Disease Control Prevention (CDC) (March 2003). "FDA licensure of diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant), and poliovirus vaccine combined, (PEDIARIX) for use in infants". MMWR Morb. Mortal. Wkly. Rep. 52 (10): 203–4. PMID 12653460.
    3. Centers for Disease Control Prevention (CDC) (October 2008). "Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose". MMWR Morb. Mortal. Wkly. Rep. 57 (39): 1078–9. PMID 18830212.
    4. Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP (January 2018). "Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices". MMWR Recomm Rep. 67 (1): 1–31. doi:10.15585/mmwr.rr6701a1. PMC 5837403. PMID 29939980.
    5. "Pediarix". Food and Drug Administration (FDA). 21 February 2018. Archived from the original on 22 September 2019. Retrieved 22 September 2019.
    This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.